CLINICAL_TRIALS
trial_result
· 2017-02-16
Clinical Trial Update: A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus [Phase 2]
Summary
A Phase 2 6-week study of PF-05175157 in Type 2 diabetes was terminated, but results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: TERMINATED | Results posted: 2017-02-16